As of May 2026, FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, with a public comment period closing June 29, 2026
For people comparing options between brand-name and compounded versions, the semaglutide vs tirzepatide comparison page covers broader differences between GLP-1 receptor agonists
Digital Life, Thinking about Future 02:20:10 Worry, Meditation 02:24:22 Beliefs, God
Though the absolute risk appears to be small, more study is warranted to confirm whether GLP-1s can negatively affect some peoples sense of smell and taste, the researchers say
The detailed breakdown in the AOD 9604 side effects guide covers everything reported in clinical and anecdotal settings